Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
American WellAMWL +0.17%50 Debt-to-Equity is 0.01 as of Jun. 2026, which is 50% below its 10-year median of 0.02. GuruFocus rates AMWL with a GF Score™ of 50/100 and a GF Value™ of $6.41 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 560 Healthcare Providers & Services companies, American Well ranks better than 99.82% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for American Well's Debt-to-Equity or its related term are showing as below:
AMWL'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.04 Med: 0.02 Max: 0.03
Current: 0.01
During the past 8 years, the highest Debt-to-Equity Ratio of American Well was 0.03. The lowest was -0.04. And the median was 0.02.
AMWL's Debt-to-Equity is ranked better than 99.82% of 560
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs AMWL: 0.01
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
American Well Debt-to-Equity Related Terms
American Well Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for American Well's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, American Well's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Well Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, American Well's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where American Well's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Well (AMWL) has a Debt-to-Equity of 0.01 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on American Well and its competitors. This is 50% below median its historical median of 0.02. According to the industry distribution chart, American Well ranks #1 out of 560 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is American Well's Debt-to-Equity too high?
American Well's current Debt-to-Equity of 0.01 is 50% below median its 10-year median of 0.02. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. American Well's value of 0.01 is 97.6% below this industry median. Based on the distribution chart, American Well ranks #1 out of 560 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, American Well has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does American Well's Debt-to-Equity compare to LFMD and SY?
According to the Healthcare Providers & Services industry distribution chart, American Well ranks #1 out of 560 companies for Debt-to-Equity. This places American Well in the top 0% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.42. American Well's value of 0.01 is 97.6% below this benchmark. While the company's 10-year median is 0.02 vs. the industry median of 0.42, American Well has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. American Well's current Debt-to-Equity of 0.01 is 97.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on American Well and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. American Well's current Debt-to-Equity is 0.01, which is 50% below median its own 10-year median of 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Well stock overvalued right now?
Based on GuruFocus' analysis, American Well (AMWL) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.41, compared to a current price of $11.92 — trading 86% above its estimated fair value. The current Debt-to-Equity is 0.01, which is 50% below median its 10-year median of 0.02 and 97.6% below the Healthcare Providers & Services industry median of 0.42. American Well's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For American Well (AMWL), the current Debt-to-Equity is 0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is American Well (AMWL) Overvalued in 2026?
Based on GuruFocus' analysis, American Well stock appears to be overvalued.
The current stock price of $11.92 is trading 86% above its estimated GF Value™ of $6.41.
GuruFocus considers American Well to be Significantly Overvalued.
Key valuation signals for AMWL:
Debt-to-Equity: 0.01 (50% below median its 10-year median of 0.02)
GF Value™: $6.41 vs. price of $11.92 (86% above fair value)
Industry Position: 97.6% below the Healthcare Providers & Services median (#1 of 560)
No single metric tells the full story. See the AMWL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
50GF Score
Get the complete analysis for AMWL
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMWL has been successfully added to your 
